News National Hemophilia Foundation recognizes Axium for hemophilia treatment programs
LAKE MARY, Fla. Specialty pharmacy provider Axium Healthcare Pharmacy has received recognition from the National Hemophilia Foundation for its treatment programs, Axium said.
The NHF said Axium “meets or exceeds” the standards of the organization’s Medical and Scientific Advisory Council, meaning that it has staff knowledgeable about and provides a full range of treatments, has 24-hour access to pharmacy staff and has good record-keeping, billing and product recall processes.
“As new companies enter the hemophilia market, MASAC recognition is significant,” Axium VP pharmacy operations Lien Pham said. “The MASAC recognition provides our payers, physicians and patients the assurance that the patients will always receive the optimal quality of care and service.”
Dr. Reddy’s launches generic Accolate
HYDERABAD, India Indian generic drug maker Dr. Reddy’s Labs has launched a version of an asthma drug for the U.S. market, the company said.
Dr. Reddy’s announced the launch of zafirlukast tablets in the 10-mg and 20-mg strengths. The drug is a version of AstraZeneca’s Accolate, which had sales of $50 million during the 12-month period ended in August, according to IMS Health.
The launch follows a decision in the U.S. District Court of New Jersey determining that the Dr. Reddy’s launch of the drug does not infringe on AstraZeneca’s patents. The Food and Drug Administration approved the drug last Thursday.
Steven Miesowicz appointed to new role at Diplomat Specialty Pharmacy
FLINT, Mich. Diplomat Specialty Pharmacy has promoted Steven Miesowicz to VP human resources, planning and government relations, the company said Monday.
Miesowicz previously served as the company’s senior director for human resources and as a business management consultant. He had a large role in securing the Michigan Economic Growth Authority tax credit that the company received in connection with the relocation to its new Flint, Mich., headquarters.
In his new position, Miesowicz will be responsible for human resources, strategic planning, organizational development, leading acquisition teams and working with government agencies, the company said.
“Steven brings a broad range of skills and experience that complements our core abilities and positions us for the future,” Diplomat president and CEO Phil Hagerman said.